Eric Lattman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric lattman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Lattman Today - Breaking & Trending Today
PNB Vesper gets DCGI nod to conduct Ph III trials on COVID-19 drug biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Kochi-based pharma firm s new drug shows promising results against COVID-19 The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore PB Jayakumar | February 22, 2021 | Updated 15:08 IST GPP-Baladol, a novel chemical entity (NCE) being developed by pharmaceutical research firm PNB Vesper Life Science for treating Covid-19 patients, claims to have shown promising results in the Phase 2b clinical trials. The pharma firm will soon seek Indian drug regulators approval for emergency use in the country. The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore. The clinical trial report will be submitted to the DCGI today seeking for an Emergency Use Authorisation to treat hospitalised patients in the country in a ....
PNB Vesper provides potential option to save hospitalised COVID-19 patients globally PNB Vesper provides potential option to save hospitalised COVID-19 patients globally 12 February 2021 | News Source credit: Shutterstock PNB Vesper, a leading Kerala based life sciences company, has announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General of India (DCGI) to conduct the Phase 2 Clinical trial of GPP-BALADOL in COVID-19 moderate patients with oxygen support in September 2020. The clinical trial was initiated in November 2020 at BJ Government Medical College and Sassoon General Hospital Pune, and Victoria Medical College and Research Institute, Bengaluru. The clinical trial report will now be submitted to DCGI on February 22, 2021. ....
Kerala firm successfully completes Phase 2 trials of Covid drug By IANS | Published on Thu, Feb 11 2021 22:57 IST | 0 Views
Despite the widespread use of oral contraceptives (OCPs) by women, many are not aware that it may impair their ability to recognise others emotional expressions, which may have serious consequences in interpersonal contexts, suggests a new study.. Image Source: IANS News Kochi, Feb 11 : PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients. The company had received approval from the Drug Controller General of India (DCGI) to conduct the Phase 2 trial on patients with moderate Covid and on oxygen support in September 2020. ....